Cheering on our supporters at the British Transplant Games
Whilst we know that many people we support attend the British Transplant Games, this year was the first time the British Liver Trust was one of the Games sponsors and we were therefore able to attend as a charity. What an experience it was! We joined our colleagues...
NAFLD, MASLD or fatty liver disease? Our approach to help everyone communicate clearly
In June 2023 major international liver disease societies announced that the name NAFLD was changing to MASLD. This was the result of 2 years of discussions involving clinicians, scientists and patients. The full name for fatty liver disease is now metabolic...
Obeticholic acid (OCA) licensing in the UK – update following European Medicines Agency decision
This blog was last updated on 19th December 2024 (see below) On 28th June 2024 the European Medicines Agency (EMA) announced that they were recommending that obeticholic acid (OCA), brand name Ocaliva, be taken off the market in the EU. OCA is a treatment for primary...
British Liver Trust warns of fatty liver disease tsunami, due to the link between fatty liver disease and type 2 diabetes
Two-thirds of people living with type 2 diabetes also have fatty liver disease[i] – but they may not be aware of it, warns the British Liver Trust. Fatty liver disease also significantly heightens the risk of developing type 2 diabetes. The charity urges people to...